ResearcherGifu University HospitalNo recent work listed
Akio Suzuki
Matched on ORCID iD 0000-0003-2106-2123; OpenAlex author ID A5029164270. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper
Papers 5
- Efficacy and safety of 5HT3RA, DEX, and NK1RA for the prevention of FOLFIRINOX-induced nausea and vomiting in patients with pancreatic cancer: a retrospective … Last author DOI 10.1007/s00520-023-08136-0↗
- Impact of First-Line FOLFIRINOX-Induced Peripheral Neuropathy on the Efficacy of Second-Line GnP in Patients with Unresectable Advanced Pancreatic Cancer. Last author DOI 10.3390/jcm11195895↗
- Anorexia, pain and peripheral neuropathy are associated with a decrease in quality of life in patients with advanced pancreatic cancer receiving outpatient che… Last author DOI 10.1186/s40780-021-00210-1↗
- Comparison of Chemotherapy-induced Nausea and Vomiting Between Gemcitabine Plus Nab-paclitaxel Combination Chemotherapy and Gemcitabine Monotherapy in Patients… Last author DOI 10.21873/anticanres.15154↗
- Severe Neutropenia is Associated with Better Clinical Outcomes in Patients with Advanced Pancreatic Cancer Who Receive Modified FOLFIRINOX Therapy. Last author DOI 10.3390/cancers10110454↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shinya Uemura · 5 shared papers, 2018–2023 · strength 0.67
- Paper Efficacy and safety of 5HT3RA, DEX, and NK1RA for the prevention of FOLFIRINOX-induced nausea and vomiting in patients … DOI 10.1007/s00520-023-08136-0↗
- Paper Impact of First-Line FOLFIRINOX-Induced Peripheral Neuropathy on the Efficacy of Second-Line GnP in Patients with Unres… DOI 10.3390/jcm11195895↗
- Paper Comparison of Chemotherapy-induced Nausea and Vomiting Between Gemcitabine Plus Nab-paclitaxel Combination Chemotherapy… DOI 10.21873/anticanres.15154↗
- Koichi Ohata · 5 shared papers, 2018–2023 · strength 0.67
- Paper Efficacy and safety of 5HT3RA, DEX, and NK1RA for the prevention of FOLFIRINOX-induced nausea and vomiting in patients … DOI 10.1007/s00520-023-08136-0↗
- Paper Impact of First-Line FOLFIRINOX-Induced Peripheral Neuropathy on the Efficacy of Second-Line GnP in Patients with Unres… DOI 10.3390/jcm11195895↗
- Paper Comparison of Chemotherapy-induced Nausea and Vomiting Between Gemcitabine Plus Nab-paclitaxel Combination Chemotherapy… DOI 10.21873/anticanres.15154↗
- Takuji Iwashita · 5 shared papers, 2018–2023 · strength 0.67
- Paper Efficacy and safety of 5HT3RA, DEX, and NK1RA for the prevention of FOLFIRINOX-induced nausea and vomiting in patients … DOI 10.1007/s00520-023-08136-0↗
- Paper Impact of First-Line FOLFIRINOX-Induced Peripheral Neuropathy on the Efficacy of Second-Line GnP in Patients with Unres… DOI 10.3390/jcm11195895↗
- Paper Comparison of Chemotherapy-induced Nausea and Vomiting Between Gemcitabine Plus Nab-paclitaxel Combination Chemotherapy… DOI 10.21873/anticanres.15154↗
- Masahito Shimizu · 5 shared papers, 2018–2023 · strength 0.67
- Paper Efficacy and safety of 5HT3RA, DEX, and NK1RA for the prevention of FOLFIRINOX-induced nausea and vomiting in patients … DOI 10.1007/s00520-023-08136-0↗
- Paper Impact of First-Line FOLFIRINOX-Induced Peripheral Neuropathy on the Efficacy of Second-Line GnP in Patients with Unres… DOI 10.3390/jcm11195895↗
- Paper Comparison of Chemotherapy-induced Nausea and Vomiting Between Gemcitabine Plus Nab-paclitaxel Combination Chemotherapy… DOI 10.21873/anticanres.15154↗
- Shiori Sadaka · 4 shared papers, 2021–2023 · strength 0.59
- Paper Efficacy and safety of 5HT3RA, DEX, and NK1RA for the prevention of FOLFIRINOX-induced nausea and vomiting in patients … DOI 10.1007/s00520-023-08136-0↗
- Paper Impact of First-Line FOLFIRINOX-Induced Peripheral Neuropathy on the Efficacy of Second-Line GnP in Patients with Unres… DOI 10.3390/jcm11195895↗
- Paper Comparison of Chemotherapy-induced Nausea and Vomiting Between Gemcitabine Plus Nab-paclitaxel Combination Chemotherapy… DOI 10.21873/anticanres.15154↗
- Hironori Fujii · 4 shared papers, 2018–2022 · strength 0.48
- Paper Impact of First-Line FOLFIRINOX-Induced Peripheral Neuropathy on the Efficacy of Second-Line GnP in Patients with Unres… DOI 10.3390/jcm11195895↗
- Paper Comparison of Chemotherapy-induced Nausea and Vomiting Between Gemcitabine Plus Nab-paclitaxel Combination Chemotherapy… DOI 10.21873/anticanres.15154↗
- Paper Anorexia, pain and peripheral neuropathy are associated with a decrease in quality of life in patients with advanced pa… DOI 10.1186/s40780-021-00210-1↗
- Yunami Yamada · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.